An FDA advisory panel has resoundingly rejected the supplemental new drug application for the atypical antipsychotic brexpiprazole (Rexulti, Otsuka Pharmaceutical Co., Ltd.), in combination with the ...
This month marks the 10th anniversary of Post-Traumatic Stress Disorder (PTSD) Awareness Month, a time dedicated to raising awareness and educating others about this often-overlooked psychiatric ...
Forbes contributors publish independent expert analyses and insights. I write about Black and neurodivergent identity in the workplace. Having post-traumatic stress disorder (PTSD) is far from easy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results